Clinical Trials Browser

Phase 2 × Melanoma × Tomography, X-Ray Computed × Clear all

NCT03089606 2023-11-15

Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker

Phase 2 Completed

27 enrolled 14 charts

Melanoma